{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"15"}],"units":"Participants"}],"description":"Number of participants with vertebral fractures as assessed by VFA at final scan.","groups":[{"description":"15 subjects were treated with combined 60mg denosumab every six months, 30 mg cinacalcet daily and 50 micrograms vitamin-D3 daily.","id":"OG000","title":"Combined Treatment."},{"description":"16 subjects received 60 mg denosumab every six months, placebo and 50 micrograms vitamin-D daily.","id":"OG001","title":"Denosumab Monotherapy"},{"description":"15 subjects will receive a saline injection every six months(blinded), placebo-tablets and 50 micrograms vitamin-D daily.","id":"OG002","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"One participant from the combined treatment-group was not included in the analysis due to withdrawal before the final scan.","reportingStatus":"POSTED","timeFrame":"Patients with vertebral fractures at one year reported.","title":"Vertebral Fracture Assessment - Final Scan","type":"SECONDARY","unitOfMeasure":"Participants"}